ロード中...
Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more
The objective of treatment for metastatic breast cancer (MBC) is to control the disease or disease-related symptoms. Prolonged survival has also often been achieved by chemotherapeutic regimens in this setting. Long-term administration of one therapeutic regimen is essential for prolonging survival...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956261/ https://ncbi.nlm.nih.gov/pubmed/24649151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2012.49 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|